Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.

by Darrell H S Tan, Maria Jose Rolon, Maria Ines Figueroa, Omar Sued, Ana Gun, Rupert Kaul, Janet M Raboud, Leah Szadkowski, Mark W Hull, Sharon L Walmsley, Pedro Cahn, Argentinean GARDEL research network
Published 2019-01-01